NHS National Pharmaceuticals Dasatinib and Paliperidone Injection
What the buyer wrote
Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694<br/><br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW 01/05/2023 – 30/04/2024 – (12 Months) <br/>LSNE 01/05/2023 – 30/04/2024 – (12 Months)<br/>NWLN 01/05/2023 – 30/04/2024 – (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE 01/05/2023 – 31/05/2024 (13 Months) <br/>NWLN 01/05/2023 – 31/01/2025 (21 months)
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS National Pharmaceuticals Dasatinib and Paliperidone Injection
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Lots
- 2
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Kind of work
- Pharmacy and medicines
Who the buyer named
Wellington House, 133-135 Waterloo Rd was the named contact on this notice.